pI: 6.8392 |
Length (AA): 680 |
MW (Da): 77581 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
529 | 678 | 1n08 (A) | 13 | 162 | 30.00 | 0 | 1 | 0.58 | -1.05 |
539 | 670 | 1nb0 (A) | 12 | 151 | 42.00 | 0 | 1 | 0.78 | -1.35 |
319 | 471 | 1eku (A) | 80 | 215 | 32.00 | 0.035 | 0.13 | 0.3205 | 0.69 |
536 | 670 | 1n05 (A) | 20 | 161 | 34.00 | 0.00000000017 | 1 | 0.471429 | 0.18 |
537 | 670 | 1nb0 (A) | 10 | 151 | 41.00 | 0 | 1 | 0.649959 | -0.02 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intraerythrocytic - 6 hs, intraerythrocytic - 12 hs, intraerythrocytic - 18 hs, intraerythrocytic - 24 hs, intraerythrocytic - 30 hs, intraerythrocytic - 36 hs, intraerythrocytic - 40 hs, intraerythrocytic - 48 hs. | Zhu L |
Zhu L | New insights into the Plasmodium vivax transcriptome using RNA-Seq. |
Ortholog group members (OG5_127161)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G21470 | bifunctional riboflavin kinase/FMN hydrolase |
Arabidopsis thaliana | AT5G08340 | riboflavin kinaseFAD 2 |
Arabidopsis thaliana | AT5G23330 | FAD synthetase RibF1 |
Babesia bovis | BBOV_I003450 | riboflavin kinase / FAD synthetase domain containing protein |
Brugia malayi | Bm1_08880 | riboflavin kinase |
Candida albicans | CaO19.11851 | similar to FMN, a Riboflavin kinase |
Candida albicans | CaO19.4373 | similar to FMN, a Riboflavin kinase |
Caenorhabditis elegans | CELE_R10H10.6 | Protein R10H10.6 |
Chlamydia trachomatis | CT_093 | riboflavin kinase/FAD synthase |
Drosophila melanogaster | Dmel_CG2846 | CG2846 gene product from transcript CG2846-RA |
Escherichia coli | b0025 | bifunctional riboflavin kinase/FAD synthetase |
Echinococcus granulosus | EgrG_001152500 | riboflavin kinase |
Entamoeba histolytica | EHI_033240 | Riboflavin kinase / FAD synthetase, putative |
Echinococcus multilocularis | EmuJ_001152500 | riboflavin kinase |
Giardia lamblia | GL50803_9698 | Riboflavin kinase, FMN adenylyltransferase |
Homo sapiens | ENSG00000135002 | riboflavin kinase |
Leishmania braziliensis | LbrM.34.3070 | riboflavin kinase/fmn adenylyltransferase-like protein |
Leishmania donovani | LdBPK_353210.1 | riboflavin kinase/fmn adenylyltransferase-like protein |
Leishmania infantum | LinJ.35.3210 | riboflavin kinase/fmn adenylyltransferase-like protein |
Leishmania major | LmjF.35.3160 | riboflavin kinase/fmn adenylyltransferase-like protein |
Leishmania mexicana | LmxM.34.3160 | riboflavin kinase/fmn adenylyltransferase-like protein |
Loa Loa (eye worm) | LOAG_14151 | hypothetical protein |
Loa Loa (eye worm) | LOAG_08840 | riboflavin kinase |
Mycobacterium leprae | ML0852 | PROBABLE BIFUNCTIONAL FAD SYNTHETASE/RIBOFLAVIN BIOSYNTHESIS PROTEIN RIBF: RIBOFLAVIN KINASE (FLAVOKINASE) + FMN ADENYLYLTRANSFE |
Mus musculus | ENSMUSG00000024712 | riboflavin kinase |
Mycobacterium tuberculosis | Rv2786c | Probable bifunctional FAD synthetase/riboflavin biosynthesis protein RibF: riboflavin kinase (flavokinase) + FMN adenylyltransfe |
Mycobacterium ulcerans | MUL_2146 | bifunctional riboflavin kinase/FMN adenylyltransferase |
Neospora caninum | NCLIV_059550 | Riboflavin kinase / FAD synthetase domain containing protein (EC 2.7.1.26), related |
Oryza sativa | 4348281 | Os10g0209300 |
Oryza sativa | 4348834 | Os10g0464400 |
Oryza sativa | 4334460 | Os03g0801700 |
Onchocerca volvulus | OVOC3960 |
|
Plasmodium berghei | PBANKA_1135400 | riboflavin kinase / FAD synthase family protein, putative |
Plasmodium falciparum | PF3D7_1359100 | riboflavin kinase / FAD synthase family protein, putative |
Plasmodium knowlesi | PKNH_1112200 | riboflavin kinase / FAD synthase family protein, putative |
Plasmodium vivax | PVX_114925 | hypothetical protein, conserved |
Plasmodium yoelii | PY00264 | Riboflavin kinase / FAD synthetase, putative |
Saccharomyces cerevisiae | YDR236C | riboflavin kinase |
Schistosoma japonicum | Sjp_0086090 | ko:K00861 riboflavin kinase [EC2.7.1.26], putative |
Schistosoma mansoni | Smp_013150 | riboflavin kinase/fmn adenylyltransferase |
Schmidtea mediterranea | mk4.000508.03 | Riboflavin kinase |
Trypanosoma brucei gambiense | Tbg972.9.7600 | riboflavin kinase, putative |
Trypanosoma brucei | Tb927.9.12430 | riboflavin kinase, putative |
Trypanosoma cruzi | TcCLB.510661.174 | riboflavin kinase, putative |
Trypanosoma cruzi | TcCLB.510741.80 | riboflavin kinase, putative |
Toxoplasma gondii | TGME49_216740 | riboflavin kinase |
Treponema pallidum | TP0888 | riboflavin kinase/FMN adenylyltransferase (ribF) |
Theileria parva | TP01_0503 | hypothetical protein |
Trichomonas vaginalis | TVAG_409820 | riboflavin kinase/fmn adenylyltransferase, putative |
Trichomonas vaginalis | TVAG_135720 | riboflavin kinase/fmn adenylyltransferase, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0416 | FAD synthase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb09.211.3420 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb09.211.3420 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb09.211.3420 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb09.211.3420 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b0025 | Escherichia coli | essential | goodall |
YDR236C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1135400 | Plasmodium berghei | Essential | plasmo |
TGME49_216740 | Toxoplasma gondii | Probably essential | sidik |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.2